• Alan Crowther

    Alliance Life Sciences

  • Ian Tidswell

    Een Consulting

  • Dr. Carolin Miltenburger PhD

    Carolin Miltenburger

  • Michael Herepath

    Optimal Access Life Science Consulting Ltd.

Join us in Zurich for
EPP Life Sciences Executive Round Table 2017 on April 27, 2017

EPP_SpareParts_zw_BREED

Dear Colleagues in the International Pharma & Medical Device Pricing Arena,
We are delighted to host you in April at the EPP Life Sciences Executive Round Table. It’s a unique 1-day forum where we will discuss topics in depth with your peers in both pharma and med devices.
We will collaborate and learn from each other in discussing innovative approaches to topics trending today such as:

  • The impact of pricing under pressure
  • How to properly price under a challenging, changing global healthcare market
  • How pricing can incent the creation of incremental and breakthrough innovation
  • What are the latest pricing trends that can support effective decision making

We have gathered a team of renowned experts in the field, ready to facilitate the discussions, stretch our thinking and challenge us to think differently. They will share insights, best practices from their fields of expertise, trends they currently track and together we’ll come up with solutions in the global Life Sciences market for 2017 and beyond.
I am looking forward on welcoming you in Zurich!
Best Regards,

Alan Crowther

Main objectives?

  • Bringing together 30 pricing and market access leaders from the Pharma and MedTech industry. Together we want to initiate a thought leadership dialogue on emerging pricing and commercial topics in the global Life Sciences market.
  • At the end of the day we’re able to determine together a number of trends, which are essential for tackling the current pricing challenges and solutions in the global Life Sciences Market in 2017 and beyond.
  • These prominent developments are laying the foundation for the agenda of the upcoming 7th EPP Life Sciences Forum to be organised again in the wonderful city of Montreux. For more information on the upcoming EPP Life Sciences Forum, click here.

For who?

We want to assure a balanced level of expertise and knowledge amongst the participants. So only selected global professionals are invited.  Our target is around 30 participants from global Life Sciences top companies. Participants with the following positions: CFO’s with commercial responsibility, Financial Controllers, pricing VP’s, Commercial, Sales and Marketing VP’s, Sales Operations Directors and Directors of Pricing & Global Access.


What to expect?

  • Facilitated discussions that lead to the answers to your questions
  • Creating a forum – in separate expert tracks in the Pharma and MedTech sector – to discuss on the top pricing challenges. What is the impact on the pricing and profit optimisation function in the industry?
  • Your learning experience intensified through close and intense collaboration with peers and industry experts.
  • Being able to define your most important needs and opportunities for your business/organisation identified.

Would you like to contribute and participate to these discussions? Send a mail to els.landuyt@pricingplatform.eu to get your personal and FREE invitation for the 2017 EPP Life Sciences Executive Briefing in Zurich.


 

Become a participant in the European Pricing Platform community!

  • 1 BUILD RELATIONSHIPS

    With more than 1000 minutes of network opportunity, you have plenty of time to connect with pricing colleagues from all over Europe.

  • 2 DISCUSS

    We stimulate an atmosphere of discussion and interaction, the best way to learn.

  • 3 LEARN FROM THE BEST

    A carefully selected speaking team of top pricing professionals, all active within your industry. No general talk, but only to-the point and useful presentations.

  • 4 REFLECT & PRACTICE

    Reflect on your key priorities and how to make it really happen !  Translate your key learnings into real change.

THE PROGRAMME

The key policy-makers and stakeholders from global Life Sciences companies like Abbott, Actavis, Amgen, Bayer AG, Boston Scientific, Janssen Pharmaceuticals, Novartis, Novo Nordisk and Teva have already joined us at previous EPP Life Sciences Round Tables.

April 27th 2017
09.00 - 09.15 Introduction What to expect? Our moderator

Our moderator – Michael Herepath – is setting the scene.

09.15 - 09.35 Framing the challenges - Pharma What is going on in the Pharma industry that is impacting pricing now? Alan Crowther - CEO Alliance Life Sciences

How to address the challenge of properly pricing and incentivizing incremental and breakthrough innovation during a period of pricing pressure?

09.35 - 09.55 Framing the challenges - MedTech What is going on in the Medtech industry that is impacting pricing now? Ian Tidswell - Een GmbH

Building a sustainable ecosystem or how we should shape the healthcare ecosystem to improve societies health while fostering innovation.

9:55 - 10:00 Next step

Participants split up into two groups to join into two separate tracks on Pharma and MedTech industry.

10:00- 10.15 Pharma/Medtech Track Action Board Reflection Session

During this session the group of participants  – guided by the facilitator-  reflects on all the challenges they face today and choose a topic of intrest.

10:15 - 11:00 Pharma Track How to price Innovation?

There is a challenge in the existing models on how to price innovation. F. Ex. How to price incremental innovation that is valuable but not affordable?


Medtech track Value pricing? Or price gouging?

How should pricing be regulated/managed to eliminate negative perceptions of the industry?

11:00 - 11:15 Coffee Break Time for an energizing break
11:15 - 12:00 Pharma Track Where does policy need to go in shaping the innovative pricing environment?

Where does policy need to go in shaping the innovative pricing environment? If pricing innovation requires a change in the payer landscape, how does policy need to be challenged to make that happen?

Or

What is the role of pricing in bringing innovation into an organization? One response to pricing pressure is to seek greater innovation.


MedTech Track Using technology to segment customers and realize higher prices

Using technology to segment customers and realize higher prices. How can the MedTech industry leverage the technology?

Or

Splitting the bill: capturing incremental value by adding value to all health care system participants?

12:00 - 12:45 The Final A joint debriefing on all outcomes

The moderator and the facilitators give a joint debriefing on the outcomes of the Pharma and MedTech tracks.

12:45 - 13:15 Presentation Pharma meets MedTech Dr. Carolin Miltenburger PhD - Independant Consultant

Carolin finds it interesting to compare both the Pharma and MedTech. It looks to her that MedTech follows Pharma, but there is a lot Pharma can also learn from MedTech, e.g. co-creation of solutions between different stakeholders, managed entry schemes etc. She will share her thoughts on this during her presentation at the EPP Executive Round Table.

13:15 -14:00 Lunch Networking lunch

Contact Forum Producer

Els Landuyt

SPEAKERS AND FACILITATORS

EPP - together with its Founding Partner Alliance Life Sciences - focus on bringing together an exclusive group of pricing related professionals of the Life Sciences industries to create a one-of-a-kind learning and networking experience. To be able to achieve this, EPP invites only top level speakers, who are each of them experts in their domains. Judge for yourself!

Alan Crowther (USA)

CEO Alliance Life Sciences


About Alan

Alan Crowther, CEO for Alliance Life Sciences, is an industry recognized authority on global pricing and revenue management. With 20 years of consulting and technology experience in the Life Sciences industry, Alan’s leadership is focused on continually innovating to solve business challenges.

 

ASK A QUESTION

Ian Tidswell (Switzserland)

Independant Consultant Een Consulting


About Ian

  • Founder and lead consultant for EEN Consulting since 2016.  Focus on helping B2B companies develop best-in-class end-to-end sustainable pricing processes
  • Pricing experience (13 years)
    • Syngenta: Head of Pricing, Basel Switzerland (2012-2016)
    • Medtronic International: Pricing Transformation head, Lausanne Switzerland (2010-2012) MOST RELEVANT FOR THIS CONFERENCE
    • Vendavo: Business Consulting Director, Palo Alto and London (2003-2009)
  • Other experience
    • i2 Technologies: Program Lead and Consulting Operations, Redwood Shores, California (1998-2002) ALSO VERY RELEVANT FOR THIS CONFERENCE
    • McKinsey & Co.: Project Manager, Stamford Connecticut (1994-1998)
    • Lawrence Berkeley National Laboratory: Research Scientist, Berkeley California (1991-1994)
  • Education
    • Harvard PhD Physics (1991)
    • Imperial College, London University BSc Physics (1984)
  • Other information
    • Live in Basel, Switzerland.

 

ASK A QUESTION

Dr. Carolin Miltenburger PhD (Germany)

Payer Strategy Consultant Life Sciences Carolin Miltenburger


About Carolin

Carolin is a strategy consultant focused on market access for medical devices and pharmaceuticals. She helps companies to develop and implement strategies and organizational solutions to define and show the value of healthcare technologies (diagnostics, drugs, devices) to payers, healthcare providers and patients. Support of full product life cycle from proof of concept (POC) to patent loss (LOE). Psychologist (PhD), health economist and organizational consultant with 25+ years experience in international consultancy and global leadership positions.

ASK A QUESTION

OUR STEERING COMMITTEE FOR THE LIFE SCIENCES INDUSTRY

Sara Aswegan (Switzerland)

Senior Vice President Ultragenyx Pharmaceuticals Inc.


About Sara

Sara has recently joined Ultragenyx Pharmacuetical Inc. as Senior Vice-President. Before that she led the Product Strategy Teams for the MPS II Business in the Rare Disease Business Unit, supporting the second largest revenue contributor for Shire with ELAPRASE, as well as plans for commercial success with the development products for Hunter CNS.

Bertrand Tardivel (Switzerland)

Head of Global Pricing Takeda Pharmaceuticals International


About Bertrand

Bertrand joined Takeda in August 2013 as Head of Global Pricing. Moving from controller to consultant and business development manager for different companies, he has built a broad experience in the pharmaceutical sector. With Takeda he joined a company that for more than 230 years has been serving society with innovative medicines, helping patients reclaim valuable moments of life from illness.

Adam Plich (The Netherlands)

VP, Head of Pricing & Market Access Europe TEVA Pharmaceutical Europe


About Adam

Adam has been working with Teva since 2012 as Head of Pricing and Market Access, first based in London now in Amsterdam.  Teva Pharmaceutical is the world’s largest generic medicines producer, leveraging its portfolio of more than 1,000 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has a world-leading position in innovative treatments for disorders of the central nervous system, including pain, as well as a strong portfolio of respiratory products.

Photo Daniel Cho

Daniel Cho (Germany)

Director Marketing, Global Pricing & Competitive Portfolio Analytics - Patient Care and Monitoring Solutions Philips Healthcare


About Daniel

Daniel Cho is currently the Director of Global Pricing for Patient Care and Monitoring Systems, a 3B Euro Business Group under Philips Healthcare. He heads a team of Pricing Managers to use Pricing as a tool to maximise the profitability of PCMS by better manage the Creation, Capturing and Maintenance of the values PCMS can deliver to their end customers.

Finn Ziegler (Denmark)

Director, Global Patient Access LEO Pharma


About Finn

Finn has recently joined LEO Pharma, after having worked for 6 years as International Contracts and Pricing Manager with Amgen, responsable for pricing and contract strategy and implementation.

His specialties lie in the domain of pricing research & strategies, health economics, public procurement and reimbursement of pharmaceuticals, public policy & affairs, think tanks, parallel trade and reference pricing in the pharmaceutical industry

Alan Crowther (USA)

CEO Alliance Life Sciences


About Alan

Alan Crowther, CEO for Alliance Life Sciences, is an industry recognized authority on global pricing and revenue management. With 20 years of consulting and technology experience in the Life Sciences industry, Alan’s leadership is focused on continually innovating to solve business challenges.

 

WHAT ATTENDEES LIKED ABOUT LAST YEAR'S EVENT

Amgen

Oliver van Zon, International Pricing Director at Amgen

Strong interactive format with participants driving the break-out topics!

“This is a really good environment to be in.”

Klaas Postema, Executive Director Market Access at Actavis

I’m open to the discussion to sharpen the mind. This is a really good environment to be in.

“It’s much more lively and interactive!”

Madalina Preda, European Pricing Supervisor at Corning BV

It is much more lively and focussed on burning issues in the Life Science markets.

Meet pricing decision makers from:

VENUE

The Renaissance Zurich Tower Hotel is located in the vibrant Zurich West quarter, 5 minutes from downtown Zurich and 15 minutes from Zurich Airport. Enjoy the expertise and business services only Renaissance can offer.

Turbinenstrasse 20 – 8005 Zurich – Switzerland

t: +41 44 630 3030 f: +41 44 630 33 33

renaissancezurichtower.com

EPP PARTNERSHIPS

This unique event is organised by the European Pricing Platform together with its Founding Partner Alliance Life Sciences.

Registration for the EPP Executive Round Table